$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
如何正确应对甲状腺癌患者服用仑伐替尼的副作用?
2025-10-19 11:44:20
Check Details
塞尔帕替尼治疗RET突变型甲状腺髓样癌的疗效和安全性
2025-10-19 11:44:20
Check Details
【正确服药】仑伐替尼在甲状腺癌中最正确的用法用量是多少?
2025-10-19 11:44:20
Check Details
塞尔帕替尼治疗RET阳性甲状腺癌的效果和副作用
2025-10-19 11:44:20
Check Details
【关注】2021年塞尔帕替尼医保会给予报销吗?
2025-10-19 11:44:20
Check Details
【疗效看这里】仑伐替尼治疗甲状腺癌效果
2025-10-19 11:44:20
Check Details
RET基因变异靶向药塞尔帕替尼图片及说明
2025-10-19 11:44:20
Check Details
塞尔帕替尼在受过卡博替尼或凡德他尼治疗的RET突变型甲状腺髓样癌中的应用
2025-10-19 11:44:20
Check Details
患者使用塞尔帕替尼的禁忌和注意事项
2025-10-19 11:44:20
Check Details
【正规又便宜】仑伐替尼去哪里买最好?
2025-10-19 11:44:20
Check Details
【仔细看】仑伐替尼进医保怎么报销?报销后多少钱?
2025-10-19 11:44:20
Check Details
凡德他尼治疗甲状腺髓样癌的疗效如何?有副作用吗?
2025-10-19 11:44:20
Check Details
1
2
...
2524
2525
2526
2527
2528
2529
2530
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
2
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
3
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
4
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
5
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
6
Complete Guide to Dosage and Dose Adjustment of Entrectinib
7
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
8
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
9
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
10
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
11
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
12
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer